BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 9315475)

  • 1. Dexamethasone suppresses release of soluble TNF receptors by human monocytes concurrently with TNF-alpha suppression.
    Joyce DA; Kloda A; Steer JH
    Immunol Cell Biol; 1997 Aug; 75(4):345-50. PubMed ID: 9315475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone antagonizes IL-4 and IL-10-induced release of IL-1RA by monocytes but augments IL-4-, IL-10-, and TGF-beta-induced suppression of TNF-alpha release.
    Joyce DA; Steer JH; Kloda A
    J Interferon Cytokine Res; 1996 Jul; 16(7):511-7. PubMed ID: 8836916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor alpha and interleukin-1 alpha stimulate late shedding of p75 TNF receptors but not p55 TNF receptors from human monocytes.
    Joyce DA; Steer JH
    J Interferon Cytokine Res; 1995 Nov; 15(11):947-54. PubMed ID: 8590306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-4, IL-10 and IFN-gamma have distinct, but interacting, effects on differentiation-induced changes in TNF-alpha and TNF receptor release by cultured human monocytes.
    Joyce DA; Steer JH
    Cytokine; 1996 Jan; 8(1):49-57. PubMed ID: 8742066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein.
    Leeuwenberg JF; Dentener MA; Buurman WA
    J Immunol; 1994 May; 152(10):5070-6. PubMed ID: 7513728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma.
    Galve-de Rochemonteix B; Nicod LP; Dayer JM
    Am J Respir Cell Mol Biol; 1996 Mar; 14(3):279-87. PubMed ID: 8845179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combination of endotoxin and dexamethasone induces type II interleukin 1 receptor (IL-1r II) in monocytes: a comparison to interleukin 1 beta (IL-1 beta) and interleukin 1 receptor antagonist (IL-1ra).
    Brown EA; Dare HA; Marsh CB; Wewers MD
    Cytokine; 1996 Nov; 8(11):828-36. PubMed ID: 9047079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slow release of soluble TNF receptors by monocytes in vitro.
    Leeuwenberg JF; Jeunhomme TM; Buurman WA
    J Immunol; 1994 Apr; 152(8):4036-43. PubMed ID: 8144970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble TNF-alpha receptor and IL-1 receptor antagonist elevation in BAL in active pulmonary TB.
    Tsao TC; Li L; Hsieh M; Liao S; Chang KS
    Eur Respir J; 1999 Sep; 14(3):490-5. PubMed ID: 10543265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imbalances between tumor necrosis factor-alpha and its soluble receptor forms, and interleukin-1beta and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosis.
    Tsao TC; Hong Jh; Li LF; Hsieh MJ; Liao SK; Chang KS
    Chest; 2000 Jan; 117(1):103-9. PubMed ID: 10631206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of soluble tumor necrosis factor receptor (sTNF-R75) release by HIV adsorption on cultured human monocytes.
    Rimaniol AC; Boussin F; Herbelin A; De Groote D; Dormont D; Bach JF; Descamps-Latscha B; Zavala F
    Eur J Immunol; 1994 Sep; 24(9):2055-60. PubMed ID: 8088326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of lipocortin-1 in dexamethasone-induced suppression of PGE2 and TNF alpha release from human peripheral blood mononuclear cells.
    Sudlow AW; Carey F; Forder R; Rothwell NJ
    Br J Pharmacol; 1996 Apr; 117(7):1449-56. PubMed ID: 8730738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor.
    Franchimont D; Martens H; Hagelstein MT; Louis E; Dewe W; Chrousos GP; Belaiche J; Geenen V
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2834-9. PubMed ID: 10443688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity.
    Zylberberg H; Rimaniol AC; Pol S; Masson A; De Groote D; Berthelot P; Bach JF; Bréchot C; Zavala F
    J Hepatol; 1999 Feb; 30(2):185-91. PubMed ID: 10068094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of soluble tumour necrosis factor receptors are increased in coal miners with pneumoconiosis.
    Schins RP; Borm PJ
    Eur Respir J; 1995 Oct; 8(10):1658-63. PubMed ID: 8586118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cell contact potentiates release of soluble tumor necrosis factor (TNF) receptors from the monocyte-like cell line THP-1.
    Björnberg F; Lantz M
    J Interferon Cytokine Res; 1998 Mar; 18(3):167-74. PubMed ID: 9555978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-gamma and LPS overcome glucocorticoid inhibition of priming for superoxide release in human monocytes. Evidence that secretion of IL-1 and tumor necrosis factor-alpha is not essential for monocyte priming.
    Szefler SJ; Norton CE; Ball B; Gross JM; Aida Y; Pabst MJ
    J Immunol; 1989 Jun; 142(11):3985-92. PubMed ID: 2541203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of TNF-α, sTNF-R55 and sTNF-R75 in inflammation of acute exacerbations of chronic obstructive pulmonary disease.
    Zeng M; Wen Y; Liu LY; Wang H; Guan KP; Huang X
    Respiration; 2009; 78(4):399-403. PubMed ID: 19339767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced glucocorticoid sensitivity of monocyte interleukin-6 release in male employees with high plasma levels of tumor necrosis factor-alpha.
    Wirtz PH; von Känel R; Kunz-Ebrecht S; Ehlert U; Fischer JE
    Life Sci; 2004 May; 75(1):1-10. PubMed ID: 15102517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory properties of human serum immunoglobulin A: anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells.
    Olas K; Butterweck H; Teschner W; Schwarz HP; Reipert B
    Clin Exp Immunol; 2005 Jun; 140(3):478-90. PubMed ID: 15932509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.